Blog
Enhancing Public Accountability: Key Elements of the Public Office (Accountability) Bill 2025
Kirsty Cook
We were delighted to take part in a 15km walk on Saturday 6 September for the Dame Vera Lynn Children’s Charity (DVLCC) to raise funds for this excellent cause.
Sodium valproate (brand names include Epilim and Depakote) is a drug to treat epilepsy, bipolar disorder and migraines which, if taken in pregnancy, is associated with a significant risk of birth defects and developmental disorders often known as Fetal Valproate Syndrome (FVS).
‘One of the most devastating complications that can result from medical mismanagement during labour and delivery is hypoxic ischaemic encephalopathy’ (K McCombe and D G Bogod).
Hypoxic Ischaemic Encephalopathy (HIE) is a term used to describe brain damage caused by a lack of oxygen (hypoxia) and / or a diminished amount of blood reaching a baby’s brain. HIE can occur during pregnancy, birth or shortly thereafter.
Kingsley Napley’s James Bell has been interviewed by Shelagh Fogarty on LBC radio to give his views, as head of clinical negligence, on shocking evidence that the NHS failed to respond sufficiently to concerns raised by staff - including consultants - regarding neonatal nurse Lucy Letby. Letby has been convicted of the murder of seven newborn babies and the attempted murders of six more. A number of surviving victims have been left with life changing disabilities, including cerebral palsy.
Recent reports from the NHS Race and Health Observatory (an independent body created to examine ethnic inequalities), and the Government’s Healthcare Safety Investigation Branch (HSIB) highlight that ethnic minority babies are at a greater risk of inaccurate assessments, late diagnosis of conditions and poorer outcomes than white babies.
Legal Notices | Privacy Notice | Fraud Warning | Modern Slavery Statement | Complaints | Website Terms | Cookie Policy | Accessibility | Site Map
© 2025 Kingsley Napley LLP. All rights reserved. Authorised and regulated by the Solicitors Regulation Authority, registration number 500046.
Skip to content Home About Us Insights Services Contact Accessibility